Clinical Trials

Potomac Urology is currently recruiting for the clinical trials listed on this page. Please contact us if you are interested in participating and want to learn more about enrollment.

Enlarged Prostate/Benign Prostatic Hyperplasia

No active trials at this time.

Prostate Cancer

ASM Study

Development and Validation of Biomarker-based tests for Disease Progression in Prostate Cancer Patients

Phase 1 = Assess urine and blood samples in men with NCCN very low/low/favorable intermediate risk prostate cancer undergoing radical prostatectomy to rule in/out the presence of high-risk prostate cancer

Phase 2 = Assess urine and blood samples in men managed with active surveillance for prostate cancer to rule in/out the presence of high-risk prostate cancer

Myovant 058

A Multi-Center, Prospective, Observational Study of Patients Being Treated with Orgovyx (OPTYX)

This is a multi-center, prospective, observational study of patients being treated with ORGOVYX. The goal of this study is to generate real-world evidence about the safety and effectiveness of ORGOVYX in patients with prostate cancer in routine clinical care and the clinical course during treatment with and following cessation of ORGOVYX.

More Information on Myovant 058

Patient Brochure

PYLARIFY

A Prospective Observational Multicenter Real-World Registry Assessing the Impact of the use of PYLARIFY® (piflufolastat F 18) PET in Patients with Newly Diagnosed and Recurrent Prostate Cancer

More Information on PLYARIFY Study

A Randomized Controlled Trial of Prostatak as Adjuvant to Up-front Radiation Therapy for Localized Prostate Cancer

**NOT CURRENTLY ENROLLING**

More Information on This Trial

Upcoming Trials

Prostate Cancer

Dendreon Booster Study

Bladder Cancer

QUILT: A Study of Intravesical Bacillus Calmette-Guerin (BCG) in Combination With ALT-803 (N-803) in Patients With Non-Muscle Invasive Bladder Cancer

Enlarged Prostate/Benign Prostatic Hyperplasia

APEX: A prospective multi-site registry of real-world experience with the OPtilume BPH Catheter SystEm for treatment of men eXperiencing symptomatic BPH.

Olympus MT-08: A Post-Market, Prospective, Randomized, Controlled, Multicenter International Study to Assess the Safety of the Temporarily Implanted Nitinol Device (iTind) Compared to the UroLift® System in Subjects with Symptomatic Benign Prostatic Hyperplasia (BPH) / Post-Market Study to Assess iTind Safety Compared to UroLift

Completed Trials

• A Pivotal Cross-Sectional Study for Bladder Cancer Detection Using a Non-invasive Urinary Biomarker Uro17 in Patients with Suspected Bladder Cancer (KDx)
• Prospective Collection of Urine Samples from Men Undergoing Prostate Biopsy (Select MDx)
• Follow-up Evaluation of Men Previously Enrolled and Diagnosed with Prostate Cancer Who Underwent Radical Prostatectomy (Select MDx sub-study)
• Immunophenotyping of Myeloid and Lymphoid Cells to Predict Prostate Cancer in At-Risk Men (Anixa)
• A Randomized, Multicenter, Two-Arm, Single-Dose, Double-Blind, Placebo-CONtrolled Phase 3
• Study of Intravesical QapzolaTM (Apaziquone) as a Chemotherapy Adjuvant to TransUrEthral Resection of Bladder Tumors in Patients with Low- to Intermediate- Risk Non-Muscle Invasive Bladder Cancer (CONQUER)
• A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Arm Study to Assess the Safety and Efficacy of a Single Treatment of BOTOX, Followed by an Optional Open-Label Treatment with BOTOX, in Female Subjects with Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS) (AbbVie M21-459)
• Randomized Study to Evaluate MACE in Patients with Prostate Cancer Treated with Relugolix or Leuprolide Acetate (Myovant 056)
• Investigating Medication versus Prostatic Urethral Lift: Assessment and Comparison of Therapies for Benign Prostatic Hyperplasia, or BPH, is a condition in which the prostate enlarges as men get older. BPH is very common – in fact, over 40% of men in their 50’s and over 70% of men in their 60’s have BPH. (IMPACT)